How This Medical Imaging Startup Went From A Barbecue Pitch To $40 Million In Funding
Vložit
- čas přidán 29. 06. 2024
- The cofounders of Genetesis, who appeared on the 2022 Forbes 30 Under 30 Healthcare list, are developing a biomagnetic imaging tool that allows doctors to measure the heart's magnetic field and diagnose cardiac issues.
Subscribe to FORBES: czcams.com/users/Forbes?s...
Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:
account.forbes.com/membership...
Stay Connected
Forbes newsletters: newsletters.editorial.forbes.com
Forbes on Facebook: forbes
Forbes Video on Twitter: / forbes
Forbes Video on Instagram: / forbes
More From Forbes: forbes.com
Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.
What's up with those blurry cameras? Who thought that was a good idea?
The EDITING hurts my eyes, is Very distracting and dumbs down this important interview. The content can stand on its own without some special effects. Focus on the content.
recession industry
respect+position+trust or you're fucked
artificial intelligence will explain everything to you, and most importantly, the meaning of these three simple words
again in some time you will wake up like now after 35 years,
but this time there will be much more serious consequence
Lmaooo, Theranos round two. They cant even describe what theyre doing
I don't want to be mean , but I would definitely be surprised if this startup didn't fail !
First of all , the founders' story is just a propensity to failure
They are more connected by their friendship than their vision
Second , the name they choose can't be more deceptive it has the connotation of biotech startup while it's a medtech one
Third, they choose the wrong place to place their startup away from the network effect can play its role cause the gov promised them to offer help I mean come on they can't even help themselves
They are delusional
Fourth , they made the typical mistake that all
Lab bench to bedside startups do obsessing over specific tech instead of a problem
In a medtech startup , you should always be placing your company to solve an unmet problem that is worth solving
Fifth , if you are new to the industry you better not starting by a totally new modality that would require everything else to change
FAKE